文献速递肾小球疾病慢性肾脏病

妊娠期狼疮患者肾脏结局及肾炎(复发/新发)危险因素的多族裔队列研究

Kidney Outcomes and Risk Factors for Nephritis (Flare/De Novo) in a Multiethnic Cohort of Pregnant Patients with Lupus.
PubMed 文献 · Clin J Am Soc Nephrol · 2017-04-11

该前瞻性队列纳入373例基线尿蛋白≤1000 mg且血肌酐<1.2 mg/dl的妊娠狼疮患者,评估妊娠期活动性肾炎。既往肾病完全或部分缓解者活动性肾炎风险显著高于无既往肾病者,低C4独立相关,而单纯抗dsDNA阳性不增加风险。

要点

  • 既往狼疮肾炎完全或部分缓解者妊娠期活动性肾炎风险显著升高。
  • 基线低C4与妊娠期肾炎复发或新发独立相关。
  • 单纯抗dsDNA阳性不增加妊娠期肾炎风险,尤其肾病缓解者。

核心结论

  • 妊娠期狼疮患者新发肾脏受累不常见,但既往肾病完全或部分缓解者活动性肾炎风险显著增高。
  • 基线低C4独立关联活动性肾炎风险,而单纯抗dsDNA阳性不构成独立风险。

研究设计与样本

  • 前瞻性队列研究,纳入373例基线尿蛋白≤1000 mg且血肌酐<1.2 mg/dl的妊娠狼疮患者,2003至2012年入组,52%为少数族裔。
  • 活动性肾炎定义为尿蛋白增加>500 mg和/或红细胞管型。

主要发现

  • 118例既往肾病患者中发生13例肾脏复发(11%),其中完全缓解89例中7例,部分缓解29例中6例。
  • 255例无既往肾病患者中新发肾脏受累4例(2%)(P<0.001)。
  • 多变量分析:既往肾病完全缓解者活动性肾炎调整OR 6.88(95%CI 1.84-25.71,P=0.004),部分缓解者调整OR 20.98(95%CI 4.69-93.98,P<0.001)。
  • 低C4与肾脏复发/新发疾病相关,调整OR 5.59(95%CI 1.64-19.13,P<0.01);低C3或单纯抗dsDNA阳性无显著关联。

关键数值与推荐

  • 活动性肾炎定义:尿蛋白增加>500 mg和/或红细胞管型。
  • 既往肾病完全缓解者活动性肾炎调整OR 6.88(95%CI 1.84-25.71,P=0.004)。
  • 既往肾病部分缓解者活动性肾炎调整OR 20.98(95%CI 4.69-93.98,P<0.001)。
  • 低C4与活动性肾炎调整OR 5.59(95%CI 1.64-19.13,P<0.01)。

临床怎么用

  • 对既往狼疮肾炎缓解的妊娠患者应加强肾脏监测,尤其部分缓解者。
  • 基线低C4提示妊娠期肾炎风险增高,需更密切随访。
  • 单纯抗dsDNA阳性而肾病缓解者不应仅因此过度担忧。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Kidney disease is a critical concern in counseling patients with lupus considering pregnancy. This study sought to assess the risk of renal flares during pregnancy in women with previous lupus nephritis in partial or complete remission, particularly in those with antidouble-stranded DNA antibodies and low complement levels, and the risk of new-onset nephritis in patients with stable/mildly active SLE. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We assessed active nephritis (renal flares and de novo kidney disease) and associated predictors during pregnancy in patients with lupus with urine protein ≤1000 mg and serum creatinine <1.2 mg/dl at baseline; 373 patients (52% ethnic/racial minorities) enrolled between 2003 and 2012 were prospectively followed in the Predictors of Pregnancy Outcome: Biomarkers in Antiphospholipid Syndrome and Systemic Lupus Erythematosus Study. Active nephritis was defined by proteinuria increase of >500 mg and/or red blood cell casts. RESULTS: Of 118 patients with previous kidney disease, 13 renal flares (11%) occurred (seven of 89 in complete remission and six of 29 in partial remission) compared with four with de novo kidney involvement (2%) in 255 patients without past kidney disease (P<0.001). Active nephritis was not associated with ethnicity, race, age, creatinine, BP, or antihypertensive and other medications. In multivariable logistic regression analyses, patients with past kidney disease in complete or partial remission more often experienced active nephritis (adjusted odds ratio, 6.88; 95% confidence interval, 1.84 to 25.71; P=0.004 and adjusted odds ratio, 20.98; 95% confidence interval, 4.69 to 93.98; P<0.001, respectively) than those without past kidney disease. Low C4 was associated with renal flares/de novo disease (adjusted odds ratio, 5.59; 95% confidence interval, 1.64 to 19.13; P<0.01) but not low C3 or positive anti-dsDNA alone. CONCLUSIONS: De novo kidney involvement in SLE, even in ethnic/racial minorities, is uncommon during pregnancy. Past kidney disease and low C4 at baseline independently associate with higher risk of developing active nephritis. Antibodies to dsDNA alone should not raise concern, even in patients with past kidney disease, if in remission.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Buyon JP, Kim MY, Guerra MM, et al. Kidney Outcomes and Risk Factors for Nephritis (Flare/De Novo) in a Multiethnic Cohort of Pregnant Patients with Lupus. Clin J Am Soc Nephrol. 2017. PMID: 28400421. doi:10.2215/CJN.11431116

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。